Erratum to: Serum bilirubin as a prognostic marker in patients with acute decompensated heart failure, (Korean J Intern Med, (2013), 28, 3, (300-305), 10.3904/kjim.2013.28.3.300);Serum bilirubin as a prognostic marker in patients with acute decompensated heart failure

Korean Journal of Internal Medicine

Volumn 28, Issue 3, 2013, Pages 300-305

  Chintanaboina, Jayakrishna ^a   Haner, Matthew S ^b   Sethi, Arjinder ^a   Patel, Nimesh ^a   Tanyous, Walid ^a   Lalos, Alexander ^c   Pancholy, Sameer ^a  

^a Wright Center for Graduate Medical Education   (United States)

^b MANSFIELD UNIVERSITY   (United States)

^c Gastrointestinal Consultants of NEPA   (United States)

Author keywords

Bilirubin; Heart failure; Liver; Prognosis

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; BILIRUBIN; BRAIN NATRIURETIC PEPTIDE; CREATININE; SODIUM;

ACUTE HEART FAILURE; AGE; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; BILIRUBIN BLOOD LEVEL; CREATININE BLOOD LEVEL; DIASTOLIC BLOOD PRESSURE; DISEASE EXACERBATION; FEMALE; GENDER; HEART ARREST; HEART EJECTION FRACTION; HEART RATE; HIGH RISK PATIENT; HOSPITAL READMISSION; HUMAN; HYPERBILIRUBINEMIA; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PROGNOSIS; PROTEIN BLOOD LEVEL; PULSE PRESSURE; RETROSPECTIVE STUDY; SODIUM BLOOD LEVEL; SYSTOLIC BLOOD PRESSURE;

EID: 84878073720     PISSN: 12263303     EISSN: 20056648     Source Type: Journal    
DOI: 10.3904/kjim.2013.28.4.513     Document Type: Erratum

References (10)

1. Liu L. Changes in cardiovascular hospitalization and comorbidity of heart failure in the United States: findings from the National Hospital Discharge Surveys 1980-2006. Int J Cardiol 2011;149:39-45.
2. Jencks SF, Williams MV, Coleman EA. Rehospitalizations among patients in the Medicare fee-for-service program. N Engl J Med 2009;360:1418-1428.
3. Lau GT, Tan HC, Kritharides L. Type of liver dysfunction in heart failure and its relation to the severity of tricuspid regurgitation. Am J Cardiol 2002;90:1405-1409.
4. Dunn GD, Hayes P, Breen KJ, Schenker S. The liver in congestive heart failure: a review. Am J Med Sci 1973;265:174-189.
5. Sherlock S. The liver in heart failure: relation of anatomical, functional, and circulatory changes. Br Heart J 1951;13:273-293.
6. Batin P, Wickens M, McEntegart D, Fullwood L, Cowley AJ. The importance of abnormalities of liver function tests in predicting mortality in chronic heart failure. Eur Heart J 1995;16:1613-1618.
7. Fuhrmann V, Kneidinger N, Herkner H, et al. Hypoxic hepatitis: underlying conditions and risk factors for mortality in critically ill patients. Intensive Care Med 2009;35:1397-1405.
8. Allen LA, Felker GM, Pocock S, et al. Liver function abnormalities and outcome in patients with chronic heart failure: data from the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) program. Eur J Heart Fail 2009;11:170-177.
9. Shinagawa H, Inomata T, Koitabashi T, et al. Prognostic significance of increased serum bilirubin levels coincident with cardiac decompensation in chronic heart failure. Circ J 2008;72:364-369.
10. Bynum TE, Boitnott JK, Maddrey WC. Ischemic hepatitis. Dig Dis Sci 1979;24:129-135.